We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine (A-TRI-WEEK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01778413
Recruitment Status : Completed
First Posted : January 29, 2013
Last Update Posted : September 2, 2015
Information provided by (Responsible Party):
Anna Cruceta, Fundació Clínic per la Recerca Biomèdica

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2014
  Study Completion Date : December 2014